-
-
-
-
-
-
-
Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update
-
-
-
-
-
-
-
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Adamis Receives FDA Approval for ZIMHI
-
-
-
-
-
-
-
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19
-
-
-
-
-
-
-
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call and Business Update
-
-
-
-
-
-
-
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 01/17: (LPCN) (TA) (KNX) Higher; (SIG) (FUL) (MS) Lower (more...)
-
1,198,585 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

